Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13486)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 10, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Singh S, Usman K, Banerjee M. Pharmacogenetic studies update in type 2 diabetes mellitus. World J Diabetes 2016; 7(15): 302-315 [PMID: 27555891 DOI: 10.4239/wjd.v7.i15.302] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v7/i15/302.htm |
| Number | Citing Articles |
| 1 |
Poongothai Venkatachalapathy, Sruthi Padhilahouse, Mohan Sellappan, Tharunika Subramanian, Shilia Jacob Kurian, Sonal Sekhar Miraj, Mahadev Rao, Ashwin Ashok Raut, Rupinder Kaur Kanwar, Jitendra Singh, Sagar Khadanga, Sukumar Mondithoka, Murali Munisamy. Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice. Pharmacogenomics and Personalized Medicine 2021; : 1441 doi: 10.2147/PGPM.S329787
|
| 2 |
Yulia Nasykhova, Yury Barbitoff, Ziravard Tonyan, Maria Danilova, Ivan Nevzorov, Tatiana Komandresova, Anastasiia Mikhailova, Tatiana Vasilieva, Olga Glavnova, Maria Yarmolinskaya, Evgenia Sluchanko, Andrey Glotov. Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus. Genes 2022; 13(8): 1310 doi: 10.3390/genes13081310
|
| 3 |
Anna-Therese Lehnich, Wolfgang Rathmann. Pharmakogenetik neuer Glukosespiegelsenker: eine Chance für die Präzisionsmedizin?. Die Diabetologie 2023; 19(2): 124 doi: 10.1007/s11428-022-00993-3
|
| 4 |
Yan Chen, Ying Zhao, Yan-Bo Li, Yan-Jun Wang, Gui-Zhen Zhang. Detection of SNPs of T2DM susceptibility genes by a ligase detection reaction–fluorescent nanosphere technique. Analytical Biochemistry 2018; : 38 doi: 10.1016/j.ab.2017.11.003
|
| 5 |
Gaia Chiara Mannino, Francesco Andreozzi, Giorgio Sesti. Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine. Diabetes/Metabolism Research and Reviews 2019; 35(3) doi: 10.1002/dmrr.3109
|
| 6 |
Jing Chen, Xianjun Meng. Aronia melanocarpa Anthocyanin Extracts Improve Hepatic Structure and Function in High-Fat Diet-/Streptozotocin-Induced T2DM Mice. Journal of Agricultural and Food Chemistry 2022; 70(37): 11531 doi: 10.1021/acs.jafc.2c03286
|
| 7 |
Mahmoud M. Sirdah, N. Scott Reading. Genetic predisposition in type 2 diabetes: A promising approach toward a personalized management of diabetes. Clinical Genetics 2020; 98(6): 525 doi: 10.1111/cge.13772
|
| 8 |
Devi Trisna Ramadhani, Rafi Amanda Rezkia Amradani, Mila Ulfia, Suryaningtyas Margi Utami, Dono Indarto, Brian Wasita. The Comparative Effect of Pomegranate Peel Extract and Dapagliflozin on Body Weight of Male Albino Wistar Rats with Type 2 Diabetes Mellitus. IOP Conference Series: Materials Science and Engineering 2019; 546(6): 062023 doi: 10.1088/1757-899X/546/6/062023
|
| 9 |
Rene Markovič, Vladimir Grubelnik, Tadej Završnik, Helena Blažun Vošner, Peter Kokol, Matjaž Perc, Marko Marhl, Matej Završnik, Jernej Završnik. Profiling of patients with type 2 diabetes based on medication adherence data. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1209809
|
| 10 |
Maryam Mazraesefidi, Mehdi Mahmoodi, Mohammadreza Hajizadeh. Effects of silibinin on apoptosis and insulin secretion in rat RINm5F pancreatic β-cells. Biotechnic & Histochemistry 2023; 98(3): 201 doi: 10.1080/10520295.2022.2154840
|
| 11 |
Robert Vigersky, Maneesh Shrivastav. Role of continuous glucose monitoring for type 2 in diabetes management and research. Journal of Diabetes and its Complications 2017; 31(1): 280 doi: 10.1016/j.jdiacomp.2016.10.007
|
| 12 |
Francesco Liguori, Elisa Mascolo, Fiammetta Vernì. The Genetics of Diabetes: What We Can Learn from Drosophila. International Journal of Molecular Sciences 2021; 22(20): 11295 doi: 10.3390/ijms222011295
|
| 13 |
Elizabeth Paz-Pacheco, Jose B Nevado, Eva Maria C Cutiongco-de la Paz, Gabriel V Jasul, Aimee Yvonne Criselle L Aman, Elizabeth Laurize A Ribaya, Mark David G Francisco, Ma Luz Vicenta V Guanzon, May L Uyking-Naranjo, Ma Cecille S Añonuevo-Cruz, Maria Patricia Deanna D Maningat, Cristina V Jaring, Paulette D Nacpil-Dominguez, Aniza B Pala-Mohamad, Abigail U Canto, John Paul M Quisumbing, Annabelle Marie M Lat, Diane Carla C Bernardo, Noemie Marie M Mansibang, Karell Jo Angelique C Calpito, Vincent Sean D Ribaya, Julius Patrick Y Ferrer, Jessica H Biwang, Jodelyn B Melegrito, Christian Deo T Deguit, Carlos Emmanuel G Panerio. Variants of SLC2A10 may be Linked to Poor Response to Metformin. Journal of the Endocrine Society 2022; 6(8) doi: 10.1210/jendso/bvac092
|
| 14 |
El Hourch Sarah, Naoual El Omri, Azeddine Ibrahimi, Rachid El Jaoudi. Metabolic and genetic studies of glimepiride and metformin and their association with type 2 diabetes. Gene Reports 2020; 21: 100787 doi: 10.1016/j.genrep.2020.100787
|
| 15 |
Hamid Reza Aghaei Meybodi, Mandana Hasanzad, Negar Sarhangi, Bagher Larijani. Precision Medicine in Clinical Practice. 2022; : 67 doi: 10.1007/978-981-19-5082-7_5
|
| 16 |
Sureka Nagarajah, Abdullah Alkandari, Pedro Marques-Vidal. Genetic risk scores: are they important for diabetes management? results from multiple cross-sectional studies. Diabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-023-01204-9
|
| 17 |
Maria Assunta Potenza, Carmela Nacci, Maria Antonietta De Salvia, Luca Sgarra, Massimo Collino, Monica Montagnani. Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options. Pharmacological Research 2017; 120: 226 doi: 10.1016/j.phrs.2017.04.009
|
| 18 |
Na Wu, Haitao Shen, Yanjun Wang, Bing He, Yongyan Zhang, Yu Bai, Runyu Du, Qiang Du, Ping Han. Role of the PKCβII/JNK signaling pathway in acute glucose fluctuation-induced apoptosis of rat vascular endothelial cells. Acta Diabetologica 2017; 54(8): 727 doi: 10.1007/s00592-017-0999-5
|
| 19 |
Shalini Singh, Ashwin Kumar Shukla, Kauser Usman, Monisha Banerjee. Pharmacogenetic impact of SLC22A1 gene variant rs628031 (G/A) in newly diagnosed Indian type 2 diabetes patients undergoing metformin monotherapy. Pharmacogenetics and Genomics 2023; 33(3): 51 doi: 10.1097/FPC.0000000000000493
|
| 20 |
Zainonesa Abrahams-October, Rabia Johnson, Mongi Benjeddou, Ruben Cloete. The determination of the effect(s) of solute carrier family 22-member 2 (SLC22A2) haplotype variants on drug binding via molecular dynamic simulation systems. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21291-4
|
| 21 |
Elahe Mohammadi, Behzad Behnam, Reza Mohammadinejad, Paul C. Guest, Luis E. Simental-Mendía, Amirhossein Sahebkar. Studies on Biomarkers and New Targets in Aging Research in Iran. Advances in Experimental Medicine and Biology 2021; 1291: 151 doi: 10.1007/978-3-030-56153-6_9
|
| 22 |
Marcello Tucci, Elisa Roca, Laura Ferrari, Anna Pia, Alberto Dalla Volta, Francesca Bedussi, Consuelo Buttigliero, Giorgio Vittorio Scagliotti, Sandra Sigala, Alfredo Berruti. Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents. Endocrine 2019; 64(3): 724 doi: 10.1007/s12020-019-01947-4
|
| 23 |
Z Abrahams-October, L Xhakaza, B Pearce, C Mandisa Masilela, M Benjeddou, O Vincent Adeniyi, R Johnson, J Jebio Ongole. Genetic association of solute carrier transporter gene variants with metformin response. Balkan Journal of Medical Genetics 2021; 24(1): 47 doi: 10.2478/bjmg-2021-0004
|
| 24 |
Fangying Xie, Juliana CN Chan, Ronald CW Ma. Precision medicine in diabetes prevention, classification and management. Journal of Diabetes Investigation 2018; 9(5): 998 doi: 10.1111/jdi.12830
|
| 25 |
Maryam Mazraesefidi , Maryam Mohammad Sadeghipour , Hossein Khorramdelazad , Mahdi Mahmoodi , Alireza Khoshdel , Mohammadali Fahmidehkar , Reza Hosseiniara , Mohammad Reza Hajizadeh. Evaluation Effects of Quercetin on Streptozotocin-treated RINm5F
Pancreatic β-cells in vitro. Current Chemical Biology 2021; 15(4): 310 doi: 10.2174/2212796816666211223101206
|
| 26 |
Khaled Naja, Said El Shamieh, Rajaa Fakhoury. rs622342A>C in SLC22A1 is associated with metformin pharmacokinetics and glycemic response. Drug Metabolism and Pharmacokinetics 2020; 35(1): 160 doi: 10.1016/j.dmpk.2019.10.007
|
| 27 |
Jing Chen, Chong Ning, Jingjing Mu, Dongnan Li, Yan Ma, Xianjun Meng. Role of Wnt signaling pathways in type 2 diabetes mellitus. Molecular and Cellular Biochemistry 2021; 476(5): 2219 doi: 10.1007/s11010-021-04086-5
|
| 28 |
N. O. Pozdnyakov, I. N. Kagarmanyan, A. E. Miroshnikov, E. S. Emelyanov, A. A. Gruzdeva, A. M. Sirotkina, I. A. Dukhanina, A. A. Milkina, A. A. Khokhlov, S. O. Pozdnyakov. Pharmacogenetic Aspects of Type 2 Diabetes Treatment. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 2020; 5(3): 13 doi: 10.29413/ABS.2020-5.3.2
|
| 29 |
Rosario Dominguez Crespo Hirata, Alvaro Cerda, Fabiana Dalla Vecchia Genvigir, Mario Hiroyuki Hirata. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences 2018; 54(spe) doi: 10.1590/s2175-97902018000001005
|
| 30 |
Jose J. G. Marin, Maria A. Serrano, Maria J. Monte, Anabel Sanchez-Martin, Alvaro G. Temprano, Oscar Briz, Marta R. Romero. Role of Genetic Variations in the Hepatic Handling of Drugs. International Journal of Molecular Sciences 2020; 21(8): 2884 doi: 10.3390/ijms21082884
|
| 31 |
T. A. Kiseleva, F. V. Valeeva, D. R. Islamova. Personalized therapy of type 2 diabetes mellitus. Perm Medical Journal 2023; 40(5): 73 doi: 10.17816/pmj40573-79
|
| 32 |
P. Żelechowska, J. Agier, E. Kozłowska, E. Brzezińska‐Błaszczyk. Mast cells participate in chronic low‐grade inflammation within adipose tissue. Obesity Reviews 2018; 19(5): 686 doi: 10.1111/obr.12670
|
| 33 |
Canjun Zhu, Zhiyue Xu, Yexian Yuan, Tao Wang, Chang Xu, Cong Yin, Peipei Xie, Pingwen Xu, Hui Ye, Nirali Patel, Sarah Schaul, Lina Wang, Xiaotong Zhu, Songbo Wang, Ping Gao, Qianyun Xi, Yongliang Zhang, Gang Shu, Qingyan Jiang. Heparin impairs skeletal muscle glucose uptake by inhibiting insulin binding to insulin receptor. Endocrinology, Diabetes & Metabolism 2021; 4(3) doi: 10.1002/edm2.253
|
| 34 |
Ehab S. EL Desoky. Therapeutic Dilemma in Personalized Medicine. Current Reviews in Clinical and Experimental Pharmacology 2022; 17(2): 94 doi: 10.2174/1574884716666210525153454
|
| 35 |
Yulia A. Nasykhova, Ziravard N. Tonyan, Anastasiia A. Mikhailova, Maria M. Danilova, Andrey S. Glotov. Pharmacogenetics of Type 2 Diabetes—Progress and Prospects. International Journal of Molecular Sciences 2020; 21(18): 6842 doi: 10.3390/ijms21186842
|
| 36 |
Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Marcellino Monda, Raffaele Marfella, Celestino Sardu, Teresa Salvatore, Luca Rinaldi, Ferdinando Carlo Sasso. Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations. Diabetes, Metabolic Syndrome and Obesity 2023; : 3669 doi: 10.2147/DMSO.S390752
|
| 37 |
Nidia Samara Rodríguez-Rivera, Patricia Cuautle-Rodríguez, Fernando Castillo-Nájera, Juan Arcadio Molina-Guarneros. Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population. Biomedical Reports 2017; 7(1): 21 doi: 10.3892/br.2017.921
|